VM-26

Known as: VM 26, VM26 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2009
Highly Cited
2009
MicroRNAs control a wide array of biological processes including cell differentiation, proliferation, and apoptosis whose… (More)
Is this relevant?
Highly Cited
1998
Highly Cited
1998
The prognosis of infant ALL, characterized by a high incidence of the immature CD10 negative B-lineage ALL (proB ALL) is poor… (More)
  • figure 1
  • figure 2
  • table 1
  • table 2
Is this relevant?
Highly Cited
1996
Highly Cited
1996
A total of 68 adult patients with B-cell acute lymphoblastic leukemia (B-ALL) were treated in three consecutive adult multicenter… (More)
  • figure 1
  • figure 2
  • table 1
  • table 2
  • table 3
Is this relevant?
1995
1995
Merbarone, a novel DNA topoisomerase II (topo II) inhibitor, differs from teniposide (VM-26) in that it inhibits topo II… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 5
  • figure 6
Is this relevant?
1992
1992
This study shows that not only concanavalin A-stimulated proliferating lymphocytes but also unstimulated mouse splenic… (More)
Is this relevant?
Highly Cited
1988
Highly Cited
1988
The simultaneous development of resistance to the cytotoxic effects of several classes of natural product anticancer drugs, after… (More)
Is this relevant?
Highly Cited
1984
Highly Cited
1984
Adriamycin (doxorubicin), a potent antitumor drug in clinical use, interacts with nucleic acids and cell membranes, but the… (More)
Is this relevant?
1984
1984
Forty-two children, all over one year of age, were given vincristine, cyclophosphamide, and sequentially timed cisplatin and VM… (More)
Is this relevant?
1984
1984
Thirty-four consenting patients received VM-26 50–100 mg/m2 I.V. before surgical resection of intracerebral tumor, and drug was… (More)
  • table 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
1980
1980
Combination chemotherapy with VM-26 and ara-C was given to 14 children with acute lymphocytic leukemia who had not responded to… (More)
Is this relevant?